BRAIDO, FULVIO
 Distribuzione geografica
Continente #
EU - Europa 16.935
Totale 16.935
Nazione #
IT - Italia 16.935
Totale 16.935
Città #
Genova 13.168
Rapallo 1.920
Genoa 1.451
Vado Ligure 331
Bordighera 65
Totale 16.935
Nome #
null 200
The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners 152
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 150
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes 144
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. 143
Genuair® Usability Test: Results of a National Public Survey of the Elderly 138
Antiallergic drugs and quality of life. 132
A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. 131
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial 131
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. 128
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 128
Clara cell 16 protein in COPD sputum: A marker of small airways damage? 126
The relationship between allergen immunotherapy and omalizumab for treating asthma 126
Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. 126
Allergic diseases and their impact on quality of life. 123
RhinAsthma patient perspective: A Rasch validation study 122
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 120
Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study 120
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 120
Patient-physician relationship in the management of asthma: Multicentric approach in Latin America 120
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. 119
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation) 119
Illness perception, mood and coping strategies in allergic rhinitis: are there differences among ARIA classes of severity? 118
An update on allergen immunotherapy and asthma 118
New therapies for allergic rhinitis 118
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice 118
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect 118
Allergic rhinitis and asthma ad hoc survey: clinical and psychological perspectives. 117
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes. 117
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). 116
Long-acting bronchodilators improve health related quality of life in patients with COPD. 116
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. 115
The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Validation and assessment 115
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 114
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 114
Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study 114
Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol 113
Continuing Medical Education:an international reality 113
Biosimilars in allergic diseases 113
Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. 112
Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. 112
Quality-of-life issues in survivors to anaphylactic reactions to drugs 112
Patient-reported outcomes in asthma clinical trials 112
Minimal clinical important difference (MCID) of the Thai chronic urticaria quality of life questionnaire (CU-Q2oL) 112
Asthma treatment: 'magic bullets which seek their own targets'. 112
Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases 112
Why do doctors and patients not follow guidelines? 111
Worldwide differences on the concept of control of asthma. 111
Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? 111
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? 110
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. 109
RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergy 107
Does asthma control correlate with quality of life related to upper and lower airways? A real life study. 106
Umeclidinium for the treatment of uncontrolled asthma 106
Sleep disturbances in allergic diseases. 105
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR) 105
Randomized controlled trials and real life studies. Approaches and methodologies: A clinical point of view 105
Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. 105
Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) 105
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. 104
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. 104
InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients--the LIAISON study protocol. 104
Disease awareness in patients with COPD: measurement and extent 104
ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. 103
Cost-description and multiple imputation of missing values: the SATisfaction and adherence to COPD treatment (SAT) study 103
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 103
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context 103
Targeted therapy for allergic asthma: predicting and evaluating response to omalizumab. 102
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. 102
Chronic obstructive pulmonary disease patient well-being and its relationship with clinical and patient-reported outcomes: a real-life observational study. 102
“ Immunologia dell’apparato Respiratorio e metodiche di studio “ Cap 8 101
The link between allergic rhinitis and asthma: the united airways disease. 101
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 101
"Trying, But Failing" - The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence 101
Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. 101
Coping with asthma: is the physician able to identify patient's behaviour? 100
The ARGA study with general practitioners: Impact of medical education on asthma/rhinitis management 100
The anti-inflammatory properties of tiotropium 100
Phenotypes/endotypes-driven treatment in asthma 100
Sleep apnea risk in subjects with asthma with or without comorbid rhinitis 99
Pidotimod: The state of art 99
Disability in moderate chronic obstructive pulmonary disease: Prevalence, burden and assessment-results from a real-life study 99
LABA/LAMA Fixed Dose Combination in Chronic Obstructive Pulmonary Disease: The Impact on Health-Related Quality of Life 99
The role of Pneumococcal vaccine 99
Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. 98
The relationship between asthma control and quality-of-life impairment due to chronic cough: a real-life study. 98
Impact of asthma and comorbid allergic rhinitis on quality of life and control in patients of italian general practitioners 98
Disability in COPD and its relationship to clinical and patient-reported outcomes 96
Adherence to asthma treatments: 'We know, we intend, we advocate' 96
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 96
Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations 95
Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria 94
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 94
Patients with asthma and comorbid allergic rhinitis: is optimal quality of life achievable in real life? 93
Non-invasive ventilation in acute respiratory failure of patients with obesity hypoventilation syndrome 92
Adherence to treatment: assessment of an unmet need in asthma. 91
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy 91
Pharmacotherapy of allergic rhinitis: current options and future perspectives 90
null 90
RHINASTHMA-Children: A new quality of life tool for patients with respiratory allergy 89
Totale 11.100
Categoria #
all - tutte 55.659
article - articoli 55.154
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 505
Totale 111.318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.188 0 0 213 379 491 603 993 472 620 795 507 115
2020/20211.886 117 119 224 240 115 127 127 176 126 202 150 163
2021/20222.448 129 164 117 243 53 251 119 572 182 216 106 296
2022/20232.336 250 121 23 241 329 414 72 186 407 56 190 47
2023/20241.120 61 162 24 118 99 173 92 81 59 29 99 123
2024/2025349 47 268 34 0 0 0 0 0 0 0 0 0
Totale 17.565